I now have comprehensive information. Let me compile the full response.
National Tuberculosis Elimination Programme (NTEP)
Background and Renaming
The National Tuberculosis Elimination Programme (NTEP) is India's flagship public health initiative against tuberculosis, functioning under the National Health Mission (NHM) and administered by the Central TB Division, Ministry of Health & Family Welfare.
- Effective 1 January 2020, the Revised National TB Control Programme (RNTCP) was renamed to NTEP, reflecting India's commitment to eliminate TB 5 years ahead of the global WHO End TB target of 2030 - i.e., by 2025.
- India accounts for approximately 26% of the world's TB burden (WHO Global TB Report 2024).
Historical Timeline
| Phase | Programme | Period |
|---|
| Phase 1 | National TB Programme (NTP) | 1962-1997 |
| Phase 2 | Revised National TB Control Programme (RNTCP) | 1997-2019 |
| Phase 3 | National TB Elimination Programme (NTEP) | 2020 - present |
The NTP suffered from low treatment success rates and high default/death rates. In 1993, the government revamped the programme with international support, launching the RNTCP built on the DOTS strategy. Nationwide coverage was achieved in March 2006.
Vision and Goals
India's National Strategic Plan (NSP) 2017-2025 guides the NTEP with the vision of a "TB-Free India" by 2025. The key targets are:
- Reduce TB incidence by 80%
- Reduce TB-related deaths by 90%
- Achieve zero catastrophic costs for TB-affected families
These are aligned with the WHO End TB Strategy and the UN Sustainable Development Goal 3 (SDG 3).
Four Strategic Pillars (DTPB)
1. DETECT
- Universal Drug Susceptibility Testing (UDST) for all diagnosed TB patients
- Expansion of Designated Microscopy Centres (DMCs)
- Rapid Molecular Testing (CBNAAT/TrueNat) rolled out across districts
- Culture and Drug Susceptibility Testing (C-DST) labs at state and national levels
- Active Case Finding (ACF) in vulnerable and high-risk populations
2. TREAT
- All TB patients treated with daily fixed-dose combination (FDC) regimens
- Drug-Sensitive TB (DS-TB): 2HRZE + 4HR (6-month regimen)
- Drug-Resistant TB (DR-TB) managed through Programmatic Management of Drug-resistant TB (PMDT) framework
- Nikshay Poshan Yojana: nutritional support of ₹500/month per patient
- Free drugs, diagnostics, and treatment throughout the government health system
3. PREVENT
- BCG vaccination (continues via Universal Immunisation Programme)
- TB Preventive Therapy (TPT) for household contacts and PLHIV
- Infection control measures (AIC - Airborne Infection Control)
- Addressing social determinants - nutrition, diabetes, silicosis
4. BUILD
- Nikshay digital platform for TB notification, tracking, and surveillance
- Community engagement and inter-sectoral collaboration
- Public-Private Mix (PPM) to bring private sector TB patients into the fold
- Human resource strengthening and capacity building
Organisational Structure (5 Levels)
National Level → Central TB Division (DDG-TB, Ministry of H&FW)
State Level → State TB Cell (State TB Officer)
District Level → District TB Centre / District TB Officer (DTO)
Sub-district → Tuberculosis Unit (TU) - one per 250,000 population
PHI Level → Peripheral Health Institutions (PHC, CHC, hospitals)
- Central TB Division is headed by the Deputy Director General - TB (DDG-TB)
- National Expert Committees advise on policy, guidelines, and research
- State TB Cell and District TB Office govern state and district activities respectively
Laboratory Network
| Level | Facility | Function |
|---|
| Peripheral | Designated Microscopy Centre (DMC) | Sputum smear microscopy |
| District | Rapid Molecular Testing Lab (CBNAAT/TrueNat) | Rapid diagnosis + RIF resistance detection |
| State | Intermediate Reference Lab (IRL) | Culture, DST, quality assurance |
| National | National Reference Lab (NRL) | Research, validation, complex DST |
Treatment Categories and Regimens (DS-TB)
Patient Categories
- New patients - never treated or treated <1 month
- Previously treated - relapse, treatment after failure, treatment after loss to follow-up (LTFU)
Standard Regimens (Daily FDC - Daily Regimen since 2016)
| Phase | Drugs | Duration |
|---|
| Intensive | HRZE (Isoniazid + Rifampicin + Pyrazinamide + Ethambutol) | 2 months |
| Continuation | HR (Isoniazid + Rifampicin) | 4 months |
All patients receive Vitamin B6 (pyridoxine) as supplement to prevent INH neuropathy.
Drug-Resistant TB (DR-TB) Management - PMDT
Decentralized "Test and Treat" Approach
| Centre | Level | Function |
|---|
| District DR-TB Centre (DDR-TBC) | District | Manages uncomplicated RR-TB, H mono/poly DR-TB |
| Nodal DR-TB Centre (NDR-TBC) | ~10 million population | Manages complex DR-TB: XDR, treatment failure, intolerance |
Key DR-TB Regimens (Shorter/Longer)
- Shorter MDR-TB regimen: BDQ-based (Bedaquiline) 9-11 months
- Longer MDR-TB regimen: Individualized 18-20 months
- XDR-TB managed with newer drugs: Bedaquiline, Delamanid, Linezolid, Clofazimine
Key Schemes and Initiatives Under NTEP
| Scheme | Purpose |
|---|
| Nikshay Poshan Yojana | ₹500/month nutritional support to TB patients |
| Pradhan Mantri TB Mukt Bharat Abhiyaan (PMTBMBA) | Community/corporate support - "Ni-kshay Mitras" (patient sponsors) |
| Nikshay | Digital TB notification and patient tracking portal |
| 99DOTS | Adherence monitoring via missed call mobile technology |
| ACSM | Advocacy, Communication, Social Mobilisation activities |
| TB-HIV Collaborative Activities | Integration with NACO for co-infected patients |
TB Notification - Mandatory Obligation
Since 2012, TB notification has been mandatory for all healthcare providers - public and private. All TB cases must be notified through Nikshay (online portal). Non-notification is a punishable offence under the Epidemic Diseases Act.
DOT Strategy (Directly Observed Treatment)
DOTS remains the backbone of NTEP delivery:
- A DOT provider (health worker, community volunteer, family member) directly observes drug ingestion
- DOT centres function at PHCs, CHCs, DOTS corners, and community sites
- Video-observed treatment (VOT) is now piloted using smartphones for remote areas
TB/HIV Co-infection Management
- Collaborative TB-HIV activities are fully integrated under NTEP-NACO partnership
- All TB patients tested for HIV (Provider-Initiated HIV Testing and Counseling - PITC)
- All TB/HIV co-infected patients receive ART (regardless of CD4 count)
- Co-trimoxazole preventive therapy (CPT) for all HIV-positive TB patients
India's TB Status (WHO Report 2024)
- India: ~2.8 million estimated TB cases per year (26% of global burden)
- TB incidence rate: ~196 per 100,000 population
- TB elimination definition: <1 case per million population per year
- Treatment success rate (DS-TB): ~85%
- India still faces significant gaps in achieving the 2025 target
Challenges
- Huge private sector TB caseload not fully captured
- Drug-resistant TB burden - 32% increase in reported cases
- TB-diabetes and TB-malnutrition co-morbidity
- Social stigma and adherence issues
- Missed TB cases ("missing millions")
- COVID-19 disruption set back TB services (2020-2021)
Sources:
- Park's Textbook of Preventive and Social Medicine (23rd ed.), Chapter on NTEP/RNTCP, pp. 480-490
- NTEP Wikipedia overview
- PIB - India Speeding Towards TB Elimination
- WHO Global Tuberculosis Report 2024